See also this year's filing and all EDGAR filings for this company.
PDF Report 0001338042_2013_Aegerion_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001338042, Aegerion Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 83,748,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,143,000 |
| 3 | remainder_Assets | 198,000 |
| 4 | LiabilitiesCurrent | 16,926,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 7,762,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,077,000 |
| 9 | ResearchAndDevelopmentExpense | 25,164,000 |
| 10 | remainder_Expenses | 2,303,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -721,000 |
| 13 | remainder_ComprehensiveNetIncome | 65,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 85,089,000 |
| 1 | Liabilities | 24,688,000 |
| 2 | Expenses | 61,544,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 60,401,000 |
| 5 | NetIncome | -62,265,000 |
| 6 | ComprehensiveNetIncome | -62,232,500 |
| 7 | BaseVar | 86,053,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.27 |
| 9 | EconomicCapitalRatio | 2.51 |
Edgar->Model Mapping
Feature Distribution
Change over Time
